Decreased Bioavailability of Sustained Release Acetazolamide Dosage Forms
- 1 January 1978
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 4 (6) , 599-609
- https://doi.org/10.3109/03639047809081830
Abstract
Bioequivalence comparisons of two sustained release and an immediate release acetazolamide dosage form performed in normal human volunteers (n = 18) demonstrated a large statistical difference between the preparations. The sustained release dosage forms were 40-70% less available than the rapid release form based on comparisons of AUC data. Plasma level data from subjects given a suspension of acetazolamide yielded a biological half-life of 8.5 (± 2.54) hours which is twice that reported previously. A comparison of the AUC data and dissolution profiles generated for each dosage form showed a rank order correlation when a pH 1.2 dissolution fluid was used; however, correlation was not evident when the dissolution media was exchanged for pH 4.5 or 7.3 dissolution media.Keywords
This publication has 6 references indexed in Scilit:
- Bioavailability of Acetazolamide TabletsJournal of Pharmaceutical Sciences, 1978
- Short-Term Dose Response Characteristics of Acetazolamide in ManArchives of Ophthalmology (1950), 1977
- Enzymatic determination of acetazolamide in human plasmaAnalytica Chimica Acta, 1976
- Assay for Acetazolamide in PlasmaJournal of Pharmaceutical Sciences, 1975
- Advantages of Sustained-Release Therapy With Acetazolamide in Glaucoma*American Journal of Ophthalmology, 1963
- The binding of inhibitors to carbonic anhydrase in vivo: Drugs as markers for enzymeBiochemical Pharmacology, 1962